Immuno-oncology, known as Cancer immunotherapy, is a type of biotherapy that uses components from live organisms to treat cancer. It is also known as biologic therapy or biological response modifier (BRM) therapy. It's a cancer treatment that harnesses the body's immune system's ...Learn More

Nadeem Riaz, MD, MSc, discusses current and emerging pathways, targets, and biomarkers in immuno-oncology in this CME/MOC/CNE/CPE activity titled, "Deep Insight Into Immuno-Oncology: A Visual Exploration of Current and Emerging Pathways, Targets, and Biomarkers to Maximize ...Learn More

As one of the commonest contributors to human death, cancer has always been a key research area for scientists from all over the world. In a recently published Perspective in Nature Reviews Clinical Oncology, researchers from the International Agency for Research on Cancer predict ...Learn More

A research group at the RIKEN Center for Biosystems Dynamics Research (BDR) has discovered molecular events that determine whether cancer cells live or die. With this knowledge, they found that reduced consumption of a specific protein building block prevents the growth of cells ...Learn More

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a revolutionary gene-editing tool which has the ability to edit nearly any segment of DNA with more precise than any other DNA-editing tools. This DNA editing tool is highly used in the cancer research field in ...Learn More